April 27th 2024
Here are highlights from the week in Psychiatric Times.
The Expanding Role of Fluid Biomarkers in the Diagnosis and Management of Patients With Alzheimer Disease
View More
Clinical Consultations™: Considerations for Customizing Care Plans for Patients with Parkinson Disease Psychosis
View More
Expert Illustrations & Commentaries™: Visualizing New Therapeutic Targets in Schizophrenia
View More
Advances In™ Schizophrenia: Expanding the Therapeutic Landscape
View More
Southern California Psychiatry Conference
September 13-14, 2024
Register Now!
Updates on New and Emerging Therapies to Improve Outcomes for Patients With Major Depressive Disorder
View More
5th Annual International Congress on the Future of Neurology®
View More
2023 Annual Psychiatric Times™ World CME Conference
View More
Clinical Consultations™: Managing Depressive Episodes in Patients with Bipolar Disorder Type II
View More
Patient, Provider, and Caregiver Connection™: Exploring Unmet Needs In Postpartum Depression – Making the Case for Early Detection and Novel Treatments
View More
Medical Crossfire®: Understanding the Advances in Bipolar Disease Treatment—A Comprehensive Look at Treatment Selection Strategies
View More
'REEL’ Time Patient Counseling: The Diagnostic and Treatment Journey for Patients With Bipolar Disorder Type II – From Primary to Specialty Care
View More
More Than ‘Blue’ After Birth: Managing Diagnosis and Treatment of Post-Partum Depression
View More
Patient, Provider & Caregiver Connection™: Reducing the Burden of Parkinson Disease Psychosis with Personalized Management Plans
View More
Why Are Depressed Patients Inflamed? A New Path to Personalized Treatment in Psychiatry
May 31st 2018The studies reviewed in this article provide a new model for clinical practice-one where the treatment of depressed patients is not governed by trial and error, but rather where patients can access new interventions sooner.
Read More
The Therapeutic Cannabis User: 5 Key Issues
May 30th 2018A drug once seen as a widespread danger to society is now experiencing renewed interest as a treatment for medical conditions, including a number of mental health conditions. This brief review explores 5 key issues clinicians can consider when encountering the therapeutic cannabis user.
Read More
What’s in a Name? Name Changes for Subspecialty and the Academy of Psychosomatic Medicine
March 20th 2018The name of the subspecialty Psychosomatic Medicine has become Consultation-Liaison Psychiatry. And the Academy of Psychosomatic Medicine has changed its name to the Academy of Consultation-Liaison Psychiatry. Here's why.
Read More
The Best and Not So Great Articles of 2017
December 21st 2017Here's a hit list of publications devoted to psychotherapy topics; to issues in genomic medicine; the impact of technology, and burnout on the practice of medicine; and to more traditional clinical articles addressing diagnosis and treatment of psychiatric disorders.
Read More
Borderline Personality Disorder: Treatment Resistance Reconsidered
November 27th 2017While treatment of bipolar disorder challenging , the notion that it is treatment resistant is contradicted by longitudinal and treatment research that indicates high rates of remission over time, moderate rates of recovery, and significant response to structured treatments tailored to symptoms.
Read More